MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies

Clinical trial NCT06543511 · WITHDRAWN

Trial details

NCT number: NCT06543511
Sponsor: Dana-Farber Cancer Institute
Status: WITHDRAWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Myeloid Malignancy Myeloid Malignancies Blood Cancer Blood Cancers

Start date: 2024-07-29
Primary completion: 2028-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.